Healthcare companies are navigating a challenging environment as policy uncertainty and competitive pressures weigh on the ...

Using a tool called Automated Meiotic Mapping (AMM) that was developed at UT Southwestern Medical Center, a team of ...

Weight-loss drugs like Ozempic and Wegovy are used by more than 15 million adults in the U.S., or 4.5% of the population.

Also: A Medicare crisis and doctors’ concerns with Kennedy’s new coronavirus vaccine policy.

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

The Endocrine Society today endorsed the introduction of the bipartisan Treat and Reduce Obesity Act (TROA) in the Senate.

Among dozens of new laws signed this week by Gov. Jared Polis are consumer-friendly rules making it easier to cancel services ...

Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...

The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

By pairing semaglutide with one or two experimental antibodies designed to preserve muscle, participants lost less lean body ...

As congressional Republicans attempt to cut Medicaid spending, Democratic Gov. Katie Hobbs signed a bill that could expand ...

For patients with a body mass index (BMI) of 70 or higher, metabolic surgery is a highly effective treatment for this form of ...